Free Trial

MetLife (MET) Stock Price, News & Analysis

MetLife logo
$81.36 +1.25 (+1.56%)
(As of 12/20/2024 05:31 PM ET)

About MetLife Stock (NYSE:MET)

Key Stats

Today's Range
$79.48
$82.32
50-Day Range
$78.15
$88.25
52-Week Range
$64.61
$89.05
Volume
8.23 million shs
Average Volume
3.22 million shs
Market Capitalization
$56.34 billion
P/E Ratio
16.40
Dividend Yield
2.68%
Price Target
$88.62
Consensus Rating
Buy

Company Overview

MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it provides fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity reinsurance solutions; credit insurance products; and protection against long-term health care services. MetLife, Inc. was incorporated in 1999 and is based in New York, New York.

MetLife Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
98th Percentile Overall Score

MET MarketRank™: 

MetLife scored higher than 98% of companies evaluated by MarketBeat, and ranked 25th out of 936 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    MetLife has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 13 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    MetLife has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about MetLife's stock forecast and price target.
  • Earnings Growth

    Earnings for MetLife are expected to grow by 16.75% in the coming year, from $8.30 to $9.69 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of MetLife is 16.40, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 112.79.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of MetLife is 16.40, which means that it is trading at a less expensive P/E ratio than the Finance sector average P/E ratio of about 24.73.

  • Price to Earnings Growth Ratio

    MetLife has a PEG Ratio of 0.76. PEG Ratios below 1 indicate that a company could be undervalued.

  • Price to Book Value per Share Ratio

    MetLife has a P/B Ratio of 1.99. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    1.07% of the float of MetLife has been sold short.
  • Short Interest Ratio / Days to Cover

    MetLife has a short interest ratio ("days to cover") of 1.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in MetLife has recently increased by 24.00%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    MetLife pays a meaningful dividend of 2.63%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    MetLife has been increasing its dividend for 11 years.

  • Dividend Coverage

    The dividend payout ratio of MetLife is 43.95%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, MetLife will have a dividend payout ratio of 22.50% next year. This indicates that MetLife will be able to sustain or increase its dividend.

  • Read more about MetLife's dividend.
  • Percentage of Shares Shorted

    1.07% of the float of MetLife has been sold short.
  • Short Interest Ratio / Days to Cover

    MetLife has a short interest ratio ("days to cover") of 1.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in MetLife has recently increased by 24.00%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    MetLife has a news sentiment score of 0.25. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.72 average news sentiment score of Finance companies.
  • News Coverage This Week

    MarketBeat has tracked 13 news articles for MetLife this week, compared to 19 articles on an average week.
  • Search Interest

    30 people have searched for MET on MarketBeat in the last 30 days. This is an increase of 67% compared to the previous 30 days.
  • MarketBeat Follows

    Only 8 people have added MetLife to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, MetLife insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.31% of the stock of MetLife is held by insiders.

  • Percentage Held by Institutions

    94.99% of the stock of MetLife is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about MetLife's insider trading history.
Receive MET Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MetLife and its competitors with MarketBeat's FREE daily newsletter.

MET Stock News Headlines

New York Red Bulls head coach Sandro Schwarz yells from the sideline during the second half of the …
Red Bull Arena becomes Sports Illustrated Stadium in 13-year naming rights deal with MLS team
Red Bull Arena has become Sports Illustrated Stadium in a 13-year partnership agreement announced by the Major League Soccer runner-up
Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong
Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.
MetLife, Zurich enter Airways Pension Scheme longevity swap deal
Piper Sandler Remains a Buy on Metlife (MET)
MetLife picks Citi exec as global CIO
See More Headlines

MET Stock Analysis - Frequently Asked Questions

MetLife's stock was trading at $66.13 on January 1st, 2024. Since then, MET shares have increased by 23.0% and is now trading at $81.36.
View the best growth stocks for 2024 here
.

MetLife, Inc. (NYSE:MET) released its quarterly earnings results on Wednesday, July, 31st. The financial services provider reported $2.28 earnings per share for the quarter, topping analysts' consensus estimates of $2.13 by $0.15. MetLife's revenue for the quarter was up 7.2% on a year-over-year basis.
Read the conference call transcript
.

MetLife's board approved a stock buyback plan on Wednesday, May 1st 2024, which permits the company to repurchase $3,000,000,000 in shares, according to EventVestor. This means that the company could purchase up to 6% of its stock through open market purchases. Stock buyback plans are usually an indication that the company's management believes its shares are undervalued.

MetLife subsidiaries include Versant Health, Willing, Logan Circle Partners, American Life Insurance Company, Safeguard Health Enterprises, Grand Bank N.A., General American Life Insurance Company, and more.

MetLife's top institutional shareholders include State Street Corp (3.86%), Wellington Management Group LLP (2.68%), Geode Capital Management LLC (1.70%) and Pzena Investment Management LLC (1.39%). Insiders that own company stock include Steven J Goulart, Ramy Tadros, Marlene Debel, Bill Pappas, Susan M Podlogar and Jeh C Johnson.
View institutional ownership trends
.

Shares of MET stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that MetLife investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), Exxon Mobil (XOM), Salesforce (CRM) and Verizon Communications (VZ).

Company Calendar

Last Earnings
7/31/2024
Ex-Dividend for 12/16 Dividend
11/05/2024
Dividend Payable
12/16/2024
Today
12/22/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Finance
Industry
Life insurance
Sub-Industry
Life & Health Insurance
CUSIP
59156R10
Employees
45,000
Year Founded
1868

Price Target and Rating

Average Stock Price Target
$88.62
High Stock Price Target
$99.00
Low Stock Price Target
$80.00
Potential Upside/Downside
+8.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
13 Analysts

Profitability

Net Income
$1.58 billion
Pretax Margin
7.26%

Debt

Sales & Book Value

Annual Sales
$66.91 billion
Cash Flow
$6.59 per share
Book Value
$40.87 per share

Miscellaneous

Free Float
690,273,000
Market Cap
$56.34 billion
Optionable
Optionable
Beta
1.06

Social Links

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (NYSE:MET) was last updated on 12/23/2024 by MarketBeat.com Staff
From Our Partners